Not to say RVX  is  entirely off the radar of most large BP but someone should email this report from Makula Fund Mangement to all the Senior VP of Business Development , as well as Biotech Analysts of  major investment house , and as well to Journalists from major news publications who cover biotech and science news.  If this report got in the right hands to write an article in a major news publication it would definately give our share price some wings, Very well written report,  That being said if we see Rothchildor another major investment firm starts giving brokerage coverage on RVX that might be an indication of a Nasdaq listing or IPO is on its way